Bisphosphonates and invasive postmenopausal breast cancer riskAnalysis examines relationship between bisphosphonate use and the incidence of postmenopausal breast cancer. New genetic risk quantified Fentora: new fentanyl product for breakthrough cancer pain Administered by buccal or sublingual route, with dose titration for each patient. Ob/gyn procedure risks spreading cancer Specialists put laparoscopic power morcellation under the microscope Montreal surgeons tout success of robot prostatectomy Data suggest the costly technique is as good as open surgery, but is it any better? Kinase inhibitor offers new option for thyroid cancer Agent delays disease progression in radioiodine-resistant disease Antibody extends survival in lung cancer Ramucirumab shows promise as second-line agent Drug preserves fertility during chemo Survival also improved in women undergoing breast cancer treatment Why are too many women choosing mastectomy? Canadian study shows experiences of family and friends outweigh surgeons’ advice New cancer treatment danger: Pills vulnerable to gastric acid suppression Canadian researchers find proton pump inhibitors are linked with reduced survival in patients on oral anticancer agents First Previous 35 36 37 38 39 Next Last
